SAN FRANCISCO, Jan. 2, 2025 /PRNewswire/ -- Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, will present its latest breakthrough immunocytokine, FP008, on Jan 14, 2025, at the Biotech Showcase investor conference, following J.P. Morgan Healthcare...
Hence then, the article about fapon biopharma introduces fp008 at biotech showcase a safer and more effective immunotherapy for refractory cancers was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers )
Also on site :
- 12-year old Russian beats world chess champion
- Hundreds of popular grocery, drug-store items recalled due to ‘filth' at Midwest distribution center
- Body recovered from Lake Natoma amid search for missing man